Scholars Central

Conference abstractPublished 8 Oct 2015

Challenging clinical scenario of blood stream candida infections – An Indian experience

Authors: Uma Devi P, Sujith S, Rahul K, Dipu T S, Anil Kumar V, Vidya Menon

Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India; Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham University, AIMS Health Sciences Camp

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Candida is an important cause of bloodstream infections (BSIs), causing significant mortality and morbidity. The true burden of candidemia in India is not clear. Thus, this study was conducted to evaluate the clinical characteristics, species distribution, antifungal susceptibility and outcome of candidemia at our hospital. A total of 165 episodes of Candida BSI were identified between January 2012 and April 2014, with 115 episodes occurring in adult patients. Most of the episodes occurred in males (69.6%). Nearly 82.6% patients were between 41 to 80 years and majority of the patients were in the intensive care unit (65.2%) at the time of diagnosis. Majority of the candidemia episodes were found in the general medicine department (23.5%) followed by gastrointestinal surgery (13.9%) and medical oncology & hematology (13%). Risk factors identified were prior hospitalization within one year (83.5%), antibiotic therapy within the last one month (64.3%), indwelling urinary catheter (63.5%), central venous catheter use (59.1%), diabetes mellitus (53%), severe sepsis (45.2%), mechanical ventilation (43.5%) and surgery (36.5%). C. tropicalis (30.4%) was the leading cause of infection followed by C. parapsilosis (28.7%) and C. albicans (13%). Other non-albicans species isolated included C. haemulonii (7.8%), C. glabrata (7%), C. famata (4.3%) and C. krusei (1.7%). Antifungal susceptibility to fluconazole was 87.9% (C. parapsilosis), 100% (C. tropicalis) and 93.3% (C. albicans). Mortality was noted in 51 patients (44.3%). To conclude, rapid changes in the rate of infection, potential risk factors, and emergence of non-albicans Candida demand continued surveillance of this serious BSI.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Uma Devi P”
  • BylineArticles whose byline prints “Sujith S”
  • BylineArticles whose byline prints “Rahul K”
  • BylineArticles whose byline prints “Dipu T S”
  • BylineArticles whose byline prints “Anil Kumar V”
  • BylineArticles whose byline prints “Vidya Menon”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels